Lawmakers should take lessons from their policy failures and seek to avoid more restrictive measures like those guiding the FDA application process. Instead, lawmakers should support legislation that is risk-proportionate and flexible to the diverse preferences of consumers. This will go a long way toward preventing unintended consequences, improving public health and protecting consumer choice.

This op-ed is available in Inside Sources.